We are live on
!
Find out more
Vanguard Capital Management Portfolio holdings
AUM
$4.68T
This Fund
S&P 500
This Quarter
Est. Return
+26.64%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$4.68T
AUM Growth
+$637B
(+16%)
Cap. Flow
+$33.9B
Cap. Flow
% of AUM
0.72%
Top 10 Holdings %
Top 10 Hldgs %
32.56%
Holding
4,163
New
101
Increased
2,575
Reduced
1,196
Closed
71
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HONA
Honeywell Aerospace
HONA
|
+$4.57B |
| 2 |
SPCX
SpaceX
SPCX
|
+$4.51B |
| 3 |
Marvell Technology
MRVL
|
+$3.77B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.69B |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$1.67B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$4.59B |
| 2 |
CTRA
Coterra Energy
CTRA
|
+$1.69B |
| 3 |
Salesforce
CRM
|
+$1.28B |
| 4 |
JPMorgan Chase
JPM
|
+$1.15B |
| 5 |
HOLX
Hologic
HOLX
|
+$1.1B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 36.14% |
| 2 | Financials | 12.19% |
| 3 | Industrials | 9.6% |
| 4 | Healthcare | 9.39% |
| 5 | Consumer Discretionary | 9.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1626
Ziff Davis
ZD
$1.86B
| $86.8M | ﹤0.01% |
1,656,506
-40,423
| -2% | -$1.83M |
|
1627
Ocular Therapeutix
OCUL
$2.42B
| $86.7M | ﹤0.01% |
8,832,595
+113,556
| +1% | +$1.03M |
|
1628
Spectrum Brands
SPB
$2.02B
| $86.6M | ﹤0.01% |
1,010,425
-294
| -0% | -$23.8K |
|
1629
Ezcorp Inc
EZPW
$1.8B
| $86.6M | ﹤0.01% |
2,503,906
+43,904
| +2% | +$1.39M |
|
1630
Payoneer
PAYO
$2.42B
| $86.5M | ﹤0.01% |
12,146,285
-397,492
| -3% | -$2.18M |
|
1631
Braze
BRZE
$3.28B
| $86.4M | ﹤0.01% |
3,983,946
+53,521
| +1% | +$1.19M |
|
|
EFXT
1632
Enerflex
EFXT
$2.74B
| $86.4M | ﹤0.01% |
3,517,814
+32,608
| +0.9% | +$813K |
|
1633
Protolabs
PRLB
$2.17B
| $86M | ﹤0.01% |
1,054,623
+14,882
| +1% | +$1.05M |
|
|
ARXS
1634
Arxis Inc
ARXS
$23.6B
| $86M | ﹤0.01% |
+1,862,985
| New | +$72.7M |
|
1635
Kulicke & Soffa
KLIC
$4.82B
| $85.9M | ﹤0.01% |
642,115
+22,117
| +4% | +$2.17M |
|
1636
Syndax Pharmaceuticals
SNDX
$1.78B
| $85.9M | ﹤0.01% |
3,927,892
+105,313
| +3% | +$2.19M |
|
1637
Quantum Computing Inc
QUBT
$1.93B
| $85.8M | ﹤0.01% |
8,848,881
+86,586
| +1% | +$842K |
|
1638
Douglas Emmett
DEI
$1.94B
| $85.5M | ﹤0.01% |
7,246,985
-84,860
| -1% | -$954K |
|
1639
Gorman-Rupp
GRC
$2.13B
| $85.5M | ﹤0.01% |
931,691
+14,003
| +2% | +$1.06M |
|
1640
Encore Capital Group
ECPG
$2.2B
| $85M | ﹤0.01% |
911,277
-24,781
| -3% | -$2.02M |
|
1641
Taysha Gene Therapies
TSHA
$2.02B
| $85M | ﹤0.01% |
12,478,595
+2,247,093
| +22% | +$13.3M |
|
1642
National Bank Holdings
NBHC
$1.92B
| $84.9M | ﹤0.01% |
1,911,985
+65,137
| +4% | +$2.75M |
|
1643
Kohl's
KSS
$2.12B
| $84.7M | ﹤0.01% |
4,781,687
+37,650
| +0.8% | +$558K |
|
1644
Stoke Therapeutics
STOK
$2.07B
| $84.6M | ﹤0.01% |
2,586,937
+231,334
| +10% | +$7.42M |
|
1645
ADMA Biologics
ADMA
$2.14B
| $84.6M | ﹤0.01% |
10,103,809
-203,062
| -2% | -$1.85M |
|
|
XHR
1646
Xenia Hotels & Resorts
XHR
$1.76B
| $84.6M | ﹤0.01% |
4,153,169
-66,401
| -2% | -$1.15M |
|
1647
American Superconductor
AMSC
$1.5B
| $84.4M | ﹤0.01% |
2,034,219
-5,249
| -0.3% | -$237K |
|
1648
Babcock & Wilcox
BW
$1.36B
| $84.4M | ﹤0.01% |
5,987,572
+1,534,936
| +34% | +$26M |
|
|
BWIN
1649
Baldwin Insurance Group
BWIN
$2.92B
| $84.2M | ﹤0.01% |
3,166,381
-298,538
| -9% | -$6.45M |
|
|
AAMI
1650
Acadian Asset Management
AAMI
$3.26B
| $84.1M | ﹤0.01% |
1,176,511
+17,624
| +2% | +$1.23M |
|
Similar funds
Vanguard Capital Management's Q2 2026 Portfolio in Review
As of Q2 2026, Vanguard Capital Management held 4,163 positions worth $4.68T, up 16% from $4.04T the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Trading was light in Q2 2026: portfolio turnover was 4.1%. Vanguard Capital Management opened 101 new positions and exited 71, leaving the 4,163-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 31% a quarter earlier, followed by Financials and Industrials.
- Vanguard Capital Management's largest Q2 2026 buy was Honeywell Aerospace: 20,693,166 shares worth $4.57B.
- Vanguard Capital Management added most to Marvell Technology in Q2 2026, an estimated $3.77B increase.
- Vanguard Capital Management's biggest Q2 2026 reduction was Honeywell, cutting an estimated $4.59B.
- Vanguard Capital Management fully exited Coterra Energy in Q2 2026, selling an estimated $1.69B.
- Vanguard Capital Management's ten largest holdings make up 33% of its $4.68T portfolio in Q2 2026.
- Vanguard Capital Management opened 101 new positions and closed 71 in Q2 2026.
- Vanguard Capital Management's portfolio value rose 16% quarter-over-quarter to $4.68T.
Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.